Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

MeridianLink Inc (MLNK.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2022-02-15	19.76	-	No Rating
2023-10-20	16.72	17.00	Sell
2023-11-02	16.77	16.00	Sell
2024-02-13	18.88	17.50	Sell
2024-03-07	18.31	18.00	Sell
2024-05-12	16.74	17.00	Sell
2024-08-12	20.98	18.00	Sell
2024-11-10	24.09	25.50	Neutral
2025-03-03	18.10	20.50	Neutral
2025-03-07	21.49	21.00	Neutral
2025-05-13	17.45	19.50	Neutral

Disclosures

UBS Securities LLC makes a market in the securities and/or ADRs of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.